MXPA05010802A - Compuestos heterociclicos para el uso en el tratamiento de infecciones virales. - Google Patents
Compuestos heterociclicos para el uso en el tratamiento de infecciones virales.Info
- Publication number
- MXPA05010802A MXPA05010802A MXPA05010802A MXPA05010802A MXPA05010802A MX PA05010802 A MXPA05010802 A MX PA05010802A MX PA05010802 A MXPA05010802 A MX PA05010802A MX PA05010802 A MXPA05010802 A MX PA05010802A MX PA05010802 A MXPA05010802 A MX PA05010802A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- substituted
- viral infections
- heterocyclic compounds
- furo
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title abstract 3
- 230000009385 viral infection Effects 0.000 title abstract 3
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- -1 6-substituted-3-substituted-3H-furo[2,3-d]pyrimidin-2-one Chemical class 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 241000701022 Cytomegalovirus Species 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0309506 | 2003-04-25 | ||
| PCT/GB2004/001687 WO2004096813A1 (en) | 2003-04-25 | 2004-04-21 | Heterocyclic compounds for use in the treatment of viral infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05010802A true MXPA05010802A (es) | 2005-12-14 |
Family
ID=33397005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05010802A MXPA05010802A (es) | 2003-04-25 | 2004-04-21 | Compuestos heterociclicos para el uso en el tratamiento de infecciones virales. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20070191373A1 (https=) |
| EP (1) | EP1622913A1 (https=) |
| JP (1) | JP2006524672A (https=) |
| AU (1) | AU2004234110A1 (https=) |
| CA (1) | CA2523739A1 (https=) |
| MX (1) | MXPA05010802A (https=) |
| WO (1) | WO2004096813A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6083923A (en) * | 1997-10-31 | 2000-07-04 | Isis Pharmaceuticals Inc. | Liposomal oligonucleotide compositions for modulating RAS gene expression |
| EP2318415B1 (en) | 2008-07-15 | 2013-02-20 | Sanofi | Oxazolopyrimidines as edg-1 receptor agonists |
| AR079980A1 (es) | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de oxazolopirimidina sustituida en 2,5,7 |
| AR079981A1 (es) | 2010-01-13 | 2012-03-07 | Sanofi Aventis | Derivados de acido carboxilico que comprenden un anillo de oxoazolopirimidina 2,5,7- sustituido |
| CN102834400B (zh) * | 2010-01-14 | 2015-06-10 | 赛诺菲 | 2,5-取代的*唑并嘧啶衍生物 |
| CN102791717B (zh) * | 2010-01-14 | 2016-03-30 | 赛诺菲 | 具有2,5-取代的噁唑并嘧啶环的羧酸衍生物 |
| AR082453A1 (es) | 2010-04-21 | 2012-12-12 | Novartis Ag | Compuestos de furopiridina, composiciones farmaceuticas que los contienen y usos de los mismos |
| GB201111779D0 (en) | 2011-07-08 | 2011-08-24 | Univ Cardiff | Chemical compounds |
| WO2014140077A1 (en) | 2013-03-14 | 2014-09-18 | Glaxosmithkline Intellectual Property (No.2) Limited | Furopyridines as bromodomain inhibitors |
| BR112022025710A2 (pt) | 2020-06-19 | 2023-03-07 | Bayer Ag | 1,3,4-oxadiazol pirimidinas e 1,3,4-oxadiazol piridinas como fungicidas |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2444148A1 (en) * | 2001-04-11 | 2002-10-24 | Queen's University At Kingston | Pyrimidine compounds as anti-ictogenic and/or anti-epileptogenic agents |
-
2004
- 2004-04-21 MX MXPA05010802A patent/MXPA05010802A/es unknown
- 2004-04-21 JP JP2006506149A patent/JP2006524672A/ja not_active Withdrawn
- 2004-04-21 US US10/551,569 patent/US20070191373A1/en not_active Abandoned
- 2004-04-21 EP EP04728594A patent/EP1622913A1/en not_active Withdrawn
- 2004-04-21 CA CA002523739A patent/CA2523739A1/en not_active Abandoned
- 2004-04-21 WO PCT/GB2004/001687 patent/WO2004096813A1/en not_active Ceased
- 2004-04-21 AU AU2004234110A patent/AU2004234110A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1622913A1 (en) | 2006-02-08 |
| WO2004096813A1 (en) | 2004-11-11 |
| JP2006524672A (ja) | 2006-11-02 |
| AU2004234110A1 (en) | 2004-11-11 |
| CA2523739A1 (en) | 2004-11-11 |
| US20070191373A1 (en) | 2007-08-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69909756D1 (de) | Antivirale pyrimidinderivate | |
| DE60316013D1 (de) | Heteroaryl-pyrimidinderivate als jak-inhibitoren | |
| SG132676A1 (en) | 2,4 di (hetero) -arylamino-pyrimidine derivatives as zap-70 and/or syk inhibitors | |
| AP2065A (en) | Pyrimidine derivatives for the prevention of HIV infection | |
| NO20054404L (no) | 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon | |
| DE602004024988D1 (de) | 2-aminopyrimidin-derivate als raf-kinase-hemmer | |
| ATE254132T1 (de) | Antivirale pyrimidin nucleoside derivate | |
| MXPA03008754A (es) | Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor. | |
| NZ333706A (en) | Benzenesulfone derivatives and medicaments | |
| NO20060665L (no) | N-substituerte pyrazolyl-amidyl-benzimidazolyl C-kit inhibitorer | |
| MXPA03010961A (es) | Compuestos de tiazol utiles como inhibidores de proteinas cinasas. | |
| GEP20156282B (en) | Compounds and compositions as protein kinase inhibitors | |
| NO20024126L (no) | 2,4,Di(hetero-)arylamino(-oksy)-5-substituerte pyrimidiner som antineoplastiske midler | |
| WO2003050087A3 (en) | Novel herbicides | |
| MXPA05010802A (es) | Compuestos heterociclicos para el uso en el tratamiento de infecciones virales. | |
| UA35550C2 (uk) | Похідні урацилу, що проявляють гербіцидну активність | |
| ATE359791T1 (de) | Pyrimidin-2,4-dion-derivate als matrix- metalloproteinase-hemmer | |
| ATE389653T1 (de) | 4-substituierte derivate von pyrazolo 3,4-d pyrimidin und deren verwendungen | |
| MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
| IT1315267B1 (it) | Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale | |
| EA200600046A1 (ru) | Производные 6-[2-(фосфонометокси)алкокси]пиримидинов (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции | |
| AU2001263278A1 (en) | Cyclic gmp-specific phosphodiesterase inhibitors | |
| ATE330958T1 (de) | Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate | |
| DK1841765T5 (da) | Imidazo[4,5-C]pyridinforbindelse og fremgangsmåde til antiviral behandling | |
| MXPA03000887A (es) | Derivados heterociclicos fusionados como inhibidores de fosfodiesterasa. |